Consolidated Statements of Shareholders’ Equity - USD ($) $ in Thousands	Total	Vendor agreements	Customer agreements	Common Stock	Additional Paid-in Capital	Additional Paid-in Capital Vendor agreements	Additional Paid-in Capital Customer agreements	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021				183,367,037
Beginning balance at Dec. 31, 2021	$ 214,058			$ 18	$ 380,624			$ (4)	$ (166,580)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(79,185)								(79,185)
Other comprehensive income (loss)	(830)							(830)
Share-based compensation	24,506				24,506
Vesting of restricted stock units (in shares)				248,076
Exercise of stock options (in shares)				6,478,103
Exercise of stock options	915			$ 1	914
Exercise of warrants (in shares)				10
Vesting of warrants		$ 54	$ 9,428			$ 54	$ 9,428
Ending balance (in shares) at Jun. 30, 2022				190,093,226
Ending balance at Jun. 30, 2022	168,946			$ 19	415,526			(834)	(245,765)
Beginning balance (in shares) at Dec. 31, 2021				183,367,037
Beginning balance at Dec. 31, 2021	214,058			$ 18	380,624			(4)	(166,580)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(142,000)
Ending balance (in shares) at Dec. 31, 2022				192,924,429
Ending balance at Dec. 31, 2022	125,324			$ 19	434,478			(593)	(308,580)
Beginning balance (in shares) at Mar. 31, 2022				186,121,281
Beginning balance at Mar. 31, 2022	177,303			$ 19	403,216			(384)	(225,548)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(20,217)								(20,217)
Other comprehensive income (loss)	(450)							(450)
Share-based compensation	11,524				11,524
Vesting of restricted stock units (in shares)				248,076
Exercise of stock options (in shares)				3,723,859
Exercise of stock options	643				643
Exercise of warrants (in shares)				10
Vesting of warrants		54	89			54	89
Ending balance (in shares) at Jun. 30, 2022				190,093,226
Ending balance at Jun. 30, 2022	168,946			$ 19	415,526			(834)	(245,765)
Beginning balance (in shares) at Dec. 31, 2022				192,924,429
Beginning balance at Dec. 31, 2022	125,324			$ 19	434,478			(593)	(308,580)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(32,227)								(32,227)
Other comprehensive income (loss)	137							137
Share-based compensation	(6,490)				(6,490)
Issuance of common stock under employee stock purchase plan (in shares)				676,115
Issuance of common stock under employee stock purchase plan	168				168
Vesting of restricted stock units (in shares)				2,089,190
Exercise of stock options (in shares)				8,895,442
Exercise of stock options	1,162			$ 1	1,161
Vesting of warrants		$ 107	139			$ 107	139
Ending balance (in shares) at Jun. 30, 2023				204,585,176
Ending balance at Jun. 30, 2023	88,320			$ 20	429,563			(456)	(340,807)
Beginning balance (in shares) at Mar. 31, 2023				195,732,947
Beginning balance at Mar. 31, 2023	106,028			$ 19	425,590			(457)	(319,124)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(21,683)								(21,683)
Other comprehensive income (loss)	1							1
Share-based compensation	2,816				2,816
Issuance of common stock under employee stock purchase plan (in shares)				676,115
Issuance of common stock under employee stock purchase plan	168				168
Vesting of restricted stock units (in shares)				878,389
Exercise of stock options (in shares)				7,297,725
Exercise of stock options	927			$ 1	926
Vesting of warrants			$ 63				$ 63
Ending balance (in shares) at Jun. 30, 2023				204,585,176
Ending balance at Jun. 30, 2023	$ 88,320			$ 20	$ 429,563			$ (456)	$ (340,807)